Peer Exchange: Spring 2017 Oncology Stakeholders Summit

The Value of Regulatory and Healthcare Policy Changes in Oncology Care

May 17, 2017

Evidence-Based Oncology

At the The American Journal of Managed Care®'s Spring 2017 Oncology Stakeholders Summit, the discussion touched off-label communication, the evolving clinical trial design, and healthcare reform, all while ensuring care is patient-centered.

Q&A With Daryl Pritchard, PhD, of the Personalized Medicine Coalition

May 18, 2017

Evidence-Based Oncology

An interview with Daryl Pritchard, PhD, vice president for Science Policy at the Personalized Medicine Coalition, on the FDA's drug approval process, developments in the personalized medicine field, and reimbursement models that integrate diagnostics.

ICER's Value Assessment Framework: Capturing the Patient Experience

May 17, 2017

Evidence-Based Oncology

The Institute for Clinical and Economic Review (ICER), has established a robust health technology assessment strategy for engaging patients so that the entire process is informed by the patient experience and what “value” means to them.

Healthcare Re-Reform: Value-Based Care Remains a Constant Theme

May 16, 2017

Evidence-Based Oncology

It is a fundamental premise that providers and health systems who want to succeed in the existing uncertain healthcare environment must remain focused on delivering value-the highest-quality care at the most efficient price.